Suchergebnisse - (Person:"Pierson, Sheila K")

PubPharm (9)

1

Treatment consistent with idiopathic multicentric Castleman disease guidelines is associated with improved outcomes

enthalten in: Blood advances | 2023

von Pierson, S. | Lim, M. | Srkalovic, G. | +13

2

CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease

enthalten in: Nature communications | 2022

von Pierson, S. | Katz, L. | Williams, R. | +9

3

Increased mTORC2 pathway activation in lymph nodes of iMCD-TAFRO

enthalten in: Journal of cellular and molecular medicine | 2022

von Phillips, A. | Kakkis, J. | Tsao, P. | +2

4

Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease

enthalten in: Blood advances | 2021

von Pierson, S. | Shenoy, S. | Oromendia, A. | +22

5

Increased mTOR activation in idiopathic multicentric Castleman disease

enthalten in: Blood | 2020

von Arenas, D. | Floess, K. | Kobrin, D. | +14

CommentIn: Blood. 2020 May 7;135(19):1614-1615. - PMID 32379877

6

Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease

enthalten in: JCI insight | 2020

von Pai, R. | Japp, A. | Gonzalez, M. | +12

7

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

enthalten in: Blood | 2018

von van Rhee, F. | Voorhees, P. | Dispenzieri, A. | +39

CommentIn: Blood. 2018 Nov 15;132(20):2109-2110. - PMID 30442745

8

Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment : A Randomized Clinical Trial

enthalten in: JAMA surgery | 2015

von Courcoulas, A. | Belle, S. | Neiberg, R. | +6

CommentIn: JAMA Surg. 2015 Oct;150(10):940. - PMID 26132502

9

Urinary Incontinence Before and After Bariatric Surgery

enthalten in: JAMA internal medicine | 2015

von Subak, L. | King, W. | Belle, S. | +12

CommentIn: JAMA Intern Med. 2015 Aug;175(8):1387-8. - PMID 26098294

1
[1]